
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft
Jan 16, 2026 02:38 am UTC| Business Law Technology
A federal judge in Oakland, California, has rejected renewed attempts by OpenAI and Microsoft to dismiss a high-profile lawsuit filed by Elon Musk, allowing the case to proceed to a jury trial starting April 27. The ruling...

Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement
Jan 16, 2026 02:28 am UTC| Business Technology Law
Major publishing companies Hachette Book Group and Cengage Group have formally asked a California federal court for permission to intervene in a proposed class action lawsuit against Google, intensifying the ongoing legal...

Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation
Jan 16, 2026 02:19 am UTC| Business
JPMorgan Chase CEO Jamie Dimon has once again drawn attention to his future at the largest U.S. bank, saying he would like to remain in his role for at least five more years, comments that have reignited Wall Streets...

China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO
Jan 16, 2026 01:46 am UTC| Insights & Views Technology Business
Chinas artificial intelligence capabilities are rapidly catching up to those of the United States and other Western nations, according to Demis Hassabis, CEO of Google DeepMind. Speaking on a CNBC podcast, Hassabis said...

Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years
Jan 16, 2026 01:29 am UTC| Business
Walmart announced on Thursday that Kathryn McLay will step down as chief executive officer of Walmart International on January 31, marking a significant leadership change at the worlds largest retailer. While she will...

One Percent Rule Checklist For Safer Forex Trading Risk
Jan 15, 2026 19:18 pm UTC| Business
Many South African traders focus on finding the perfect entry but overlook the simple daily habits that keep their accounts alive. The one percent rule is one of those habits. It looks almost too basic, yet it is often the...

Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Jan 15, 2026 07:02 am UTC| Business Health Governance
Sanofi SA (EPA: SASY) has achieved a significant regulatory milestone in China after receiving approval for two of its specialty medications, Myqorzo and Redemplo. The approvals mark an important step in expanding Sanofis...